$0.8197
0.0107[1.32%]
At close: Apr 26
$0.8197
0[0.00%]
After Hours: 7:01AM EDT
CytoSorbents
(NASDAQ:CTSO)CytoSorbents Stock (NASDAQ:CTSO), Analyst Ratings, Price Targets, Predictions
CytoSorbents Corp has a consensus price target of $2.5, established from looking at the 9 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and B. Riley Securities on March 15, 2024, December 29, 2023, and September 7, 2023. With an average price target of $2 between HC Wainwright & Co., HC Wainwright & Co., and B. Riley Securities, there's an implied 143.99% upside for CytoSorbents Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
B. Riley Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for CytoSorbents
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/15/2024 | CTSO | Buy Now | CytoSorbents | $0.82 | 22% | HC Wainwright & Co. | Sean Lee | → $1 | Reiterates | Neutral → Neutral | Get Alert |
| 12/29/2023 | CTSO | Buy Now | CytoSorbents | $0.82 | 22% | HC Wainwright & Co. | Sean Lee | $5.5 → $1 | Downgrade | Buy → Neutral | Get Alert |
| 09/07/2023 | CTSO | Buy Now | CytoSorbents | $0.82 | 387.98% | B. Riley Securities | Justin Walsh | → $4 | Reinstates | Buy → Buy | Get Alert |
| 08/02/2023 | CTSO | Buy Now | CytoSorbents | $0.82 | 570.98% | HC Wainwright & Co. | Sean Lee | → $5.5 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2023 | CTSO | Buy Now | CytoSorbents | $0.82 | 570.98% | HC Wainwright & Co. | Sean Lee | → $5.5 | Reiterates | → Buy | Get Alert |
| 03/10/2023 | CTSO | Buy Now | CytoSorbents | $0.82 | 570.98% | HC Wainwright & Co. | Sean Lee | → $5.5 | Reiterates | → Buy | Get Alert |
| 11/04/2022 | CTSO | Buy Now | CytoSorbents | $0.82 | 570.98% | HC Wainwright & Co. | Sean Lee | $9 → $5.5 | Maintains | Buy | Get Alert |
| 05/04/2022 | CTSO | Buy Now | CytoSorbents | $0.82 | 631.98% | B. Riley Securities | Justin Walsh | $7 → $6 | Maintains | Buy | Get Alert |
| 05/04/2022 | CTSO | Buy Now | CytoSorbents | $0.82 | 997.96% | HC Wainwright & Co. | Sean Lee | $13 → $9 | Maintains | Buy | Get Alert |
FAQ
What is the target price for CytoSorbents (CTSO)?
The latest price target for CytoSorbents (NASDAQ: CTSO) was reported by HC Wainwright & Co. on March 15, 2024. The analyst firm set a price target for $1.00 expecting CTSO to rise to within 12 months (a possible 22.00% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CytoSorbents (CTSO)?
The latest analyst rating for CytoSorbents (NASDAQ: CTSO) was provided by HC Wainwright & Co., and CytoSorbents reiterated their neutral rating.
When was the last upgrade for CytoSorbents (CTSO)?
There is no last upgrade for CytoSorbents.
When was the last downgrade for CytoSorbents (CTSO)?
The last downgrade for CytoSorbents Corp happened on December 29, 2023 when HC Wainwright & Co. changed their price target from $5.5 to $1 for CytoSorbents Corp.
When is the next analyst rating going to be posted or updated for CytoSorbents (CTSO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CytoSorbents, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CytoSorbents was filed on March 15, 2024 so you should expect the next rating to be made available sometime around March 15, 2025.
Is the Analyst Rating CytoSorbents (CTSO) correct?
While ratings are subjective and will change, the latest CytoSorbents (CTSO) rating was a reiterated with a price target of $0.00 to $1.00. The current price CytoSorbents (CTSO) is trading at is $0.82, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.